Research Progress on the Relationship
between Osteoporosis and Cognitive Impairment

doi:10.12114/j.issn.1007-9572.2021.01.314

Chinese General Practice ›› 2022, Vol. 25 ›› Issue (11): 1406-1410.DOI: 10.12114/j.issn.1007-9572.2021.01.314

Special Issue: 骨质疏松最新文章合集；神经退行性病变最新文章合集；阿尔茨海默病最新文章合集；骨健康最新文章合集；阿尔茨海默病最新文章合集

• Review • Previous Articles

Research Progress on the Relationship between Osteoporosis and Cognitive Impairment

1.Department of Obstetrics and Gynecology，Peking University Third Hospital，Beijing 100191，China
2.Center for Reproductive Medicine，Peking University Third Hospital，Beijing 100191，China
3.Research Center of Clinical Epidemiology，Peking University Third Hospital，Beijing 100191，China
4.Department of Orthopaedics，Peking University Third Hospital，Beijing 100191，China
5.Beijing Key Laboratory of Spinal Disease Research，Beijing 100191，China
6.Engineering Research Center of Bone and Joint Precision Medicine，Ministry of Education，Beijing 100191，China
*Corresponding author：FAN Dongwei，Attending physician；E-mail：fdw@bjmu.edu.cn

Received:2021-10-12 Revised:2021-11-16 Published:2022-04-15 Online:2022-03-28

骨质疏松与认知障碍关系的研究进展

¹100191　北京市，北京大学第三医院妇产科
²100191　北京市，北京大学第三医院生殖医学中心
³100191　北京市，北京大学第三医院临床流行病学研究中心
⁴100191　北京市，北京大学第三医院骨科
⁵100191　北京市，脊柱疾病研究北京市重点实验室
⁶100191　北京市，北京大学　"骨与关节精准医学教育部工程中心"

通讯作者: 范东伟
基金资助:
国家自然科学基金资助项目(30801156，41931291)

Abstract

Abstract:

In recent years, studies have shown that among elderly comorbidities, the incidence of comorbidity between osteoporosis and cognitive impairment is increasing year by year, which is manifested as a high incidence of falls and an increased risk of fractures, which leads to disability, increased mortality, and serious harm to health and quality of life of patients with comorbidities also bring a heavy economic burden to the family and society, which has become a more difficult problem in the management of chronic diseases in the community. This article reviews the progress of the relationship between osteoporosis and cognitive impairment. The focus is on the co-morbidity mechanism, clinical risk factors and clinical features of co-morbidity between osteoporosis and cognitive impairment. It is found that osteoporosis is closely related to cognitive impairment and seriously endangers the health of the elderly. It is hoped that this article can provide ideas for exploring new risk factors for comorbidity of osteoporosis and cognitive impairment, and provide help for the effective prevention and management of patients with comorbidity of osteoporosis and cognitive impairment.

Key words: Osteoporosis, Cognition Disorders, Cognitive Dysfunction, Osteoporotic fractures, Multiple chronic conditions, Bone-brain axis

摘要：

近年研究显示，在老年共病患者中，骨质疏松与认知障碍共病的发病率逐年上升，表现为跌倒发生率高，骨折风险增加，从而引起致残、致死率升高，严重危害共病患者的健康和生活质量，同时也给家庭和社会带来沉重的经济负担，成为目前社区慢性病管理中较为棘手的问题。本文对骨质疏松与认知障碍关系的进展进行综述。重点讨论骨质疏松与认知障碍的共病机制、共病临床危险因素及共病临床特征。发现骨质疏松与认知障碍关系密切，并严重危害老年人群健康。希望本文能为探索骨质疏松与认知障碍共病新的风险因素提供思路，为有效预防和管理骨质疏松与认知障碍共病提供帮助。

关键词: 骨质疏松, 认知障碍, 认知功能障碍, 骨质疏松性骨折, 慢性病共病, 骨-脑轴

CLC Number:

R681 R741

REN Yun, TAO Liyuan, FAN Dongwei.

Research Progress on the Relationship between Osteoporosis and Cognitive Impairment [J]. Chinese General Practice, 2022, 25(11): 1406-1410.

任昀,陶立元,范东伟. 骨质疏松与认知障碍关系的研究进展[J]. 中国全科医学, 2022, 25(11): 1406-1410. DOI: 10.12114/j.issn.1007-9572.2021.01.314.

References 47

[1]	HILIGSMANN M，EVERS S M，BEN SEDRINE W，et al. A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis[J]. Pharmacoeconomics，2015，33（3）：205-224. DOI：10.1007/s40273-014-0231-1.
[2]	TURNER D A，KHIOE R F S，SHEPSTONE L，et al. The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK：economic evaluation of the SCOOP study[J]. J Bone Miner Res，2018，33（5）：845-851. DOI：10.1002/jbmr.3381.
[3]	WU J，QU Y，WANG K，et al. Healthcare resource utilization and direct medical costs for patients with osteoporotic fractures in China[J]. Value Heal Reg Issues，2019，18：106-111. DOI：10.1016/j.vhri.2018.11.008.
[4]	ZHANG C G，FENG J N，WANG S F，et al.Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study[J].PLoS Med，2020，17（8）: e1003180. DOI：10.1371/journal.pmed.1003180.
[5]	BRIGGS R，DYER A，NABEEL S，et al.Dementia in the acute hospital：the prevalence and clinical outcomes of acutely unwell patients with dementia[J].QJM，2017，110（1）：33-37. DOI：10.1093/qjmed/hcw114.
[6]	JIA L F，QUAN M N，FU Y，et al. Dementia in China：epidemiology，clinical management，and research advances[J]. Lancet Neurol，2020，19（1）：81-92. DOI：10.1016/S1474-4422(19)30290-X.
[7]	杨淞淳，吕筠，李立明.流行病学研究新进展[J]. 中华流行病学杂志，2020，41（1）：1-5. DOI：10.3760/cma.j.issn.0254-6450.2020.01.001.
[8]	SINGH I，HOOTON K，EDWARDS C，et al. Inpatient hip fractures：understanding and addressing the risk of this common injury[J]. Age Ageing，2020，49（3）：481-486. DOI：10.1093/ageing/afz179.
[9]	KERSCHAN-SCHINDL K. Prevention and rehabilitation of osteoporosis[J]. Wien Med Wochenschr，2016，166（1/2）：22-27. DOI：10.1007/s10354-015-0417-y.
[10]	WANG Y，TAO Y，HYMAN M E，et al. Osteoporosis in China[J]. Osteoporos Int，2009，20（10）：1651-1662. DOI：10.1007/s00198-009-0925-y.
[11]	NORDIN B E C，NEED A G，STEURER T，et al. Nutrition，osteoporosis，and aging[J]. Annals NY Acad Sci，1998，854（1 TOWARDS PROLO）: 336-351. DOI：10.1111/j.1749-6632.1998.tb09914.x.
[12]	DUCY P，AMLING M，TAKEDA S，et al. Leptin inhibits bone formation through a hypothalamic relay：a central control of bone mass[J]. Cell，2000，100（2）：197-207. DOI：10.1016/S0092-8674(00)81558-5.
[13]	ELEFTERIOU F. Impact of the autonomic nervous system on the skeleton[J]. Physiol Rev，2018，98（3）：1083-1112. DOI：10.1152/physrev.00014.2017.
[14]	YAVUZ KELES B，VURAL M，ÖNDER B，et al. Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women[J]. Turk J Med Sci，2020，50（4）：994-998. DOI：10.3906/sag-1909-187.
[15]	KELLY R R，MCDONALD L T，JENSEN N R，et al. Impacts of psychological stress on osteoporosis: clinical implications and treatment interactions[J]. Front Psychiatry，2019，10: 200. DOI：10.3389/fpsyt.2019.00200.
[16]	BERGER J M，SINGH P，KHRIMIAN L，et al. Mediation of the acute stress response by the skeleton[J]. Cell Metab，2019，30（5）：890-902.e8. DOI：10.1016/j.cmet.2019.08.012.
[17]	NOGUCHI T，EBINA K，HIRAO M，et al. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos，NFATc1，and NF-κB pathway[J]. Biochem Biophys Res Commun，2018，503（2）：644-650. DOI：10.1016/j.bbrc.2018.06.055.
[18]	DENGLER-CRISH C M，BALL H C，LIN L，et al. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease[J]. Neurobiol Aging，2018，67：148-158. DOI：10.1016/j.neurobiolaging.2018.03.021.
[19]	CUI S，XIONG F，HONG Y，et al. APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner[J]. J Bone Miner Res，2011，26（5）：1084-1098. DOI：10.1002/jbmr.299.
[20]	YANG M W，WANG T H，YAN P P，et al. Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice[J]. Phytomedicine，2011，18（2/3）：205-213. DOI：10.1016/j.phymed.2010.05.011.
[21]	XIA W F，JUNG J U，SHUN C，et al. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit，which are ameliorated by N-acetyl-L-cysteine[J]. J Bone Miner Res，2013，28（10）：2122-2135. DOI：10.1002/jbmr.1954.
[22]	DENGLER-CRISH C M，SMITH M A，WILSON G N. Early evidence of low bone density and decreased serotonergic synthesis in the dorsal raphe of a tauopathy model of Alzheimer's disease[J]. J Alzheimer's Dis，2016，55（4）：1605-1619. DOI：10.3233/jad-160658.
[23]	DENGLER-CRISH C M，BALL H C，LIN L，et al. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease[J]. Neurobiol Aging，2018，67：148-158. DOI：10.1016/j.neurobiolaging.2018.03.021.
[24]	BEMILLER S M，MCCRAY T J，ALLAN K，et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy[J]. Mol Neurodegener，2017，12（1）: 1-12. DOI：10.1186/s13024-017-0216-6.
[25]	GUERREIRO R，WOJTAS A，BRAS J，et al. TREM2 variants in Alzheimer's disease[J]. N Engl J Med，2013，368（2）：117-127. DOI：10.1056/nejmoa1211851.
[26]	OBRI A，KHRIMIAN L，KARSENTY G，et al. Osteocalcin in the brain：from embryonic development to age-related decline in cognition[J]. Nat Rev Endocrinol，2018，14（3）：174-182. DOI：10.1038/nrendo.2017.181.
[27]	REINHOLT F P，HULTENBY K，OLDBERG A，et al. Osteopontin——a possible anchor of osteoclasts to bone[J]. PNAS，1990，87（12）：4473-4475. DOI：10.1073/pnas.87.12.4473.
[28]	CHO E H，CHO K H，LEE H A，et al. High serum osteopontin levels are associated with low bone mineral density in postmenopausal women[J]. J Korean Med Sci，2013，28（10）: 1496. DOI：10.3346/jkms.2013.28.10.1496.
[29]	FODOR D，BONDOR C，ALBU A，et al. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women[J]. J Investig Med，2013，61（1）：15-21. DOI：10.2310/jim.0b013e3182761264.
[30]	WANG K X，DENHARDT D T. Osteopontin: role in immune regulation and stress responses[J]. Cytokine Growth Factor Rev，2008，19（5/6）：333-345. DOI：10.1016/j.cytogfr.2008.08.001.
[31]	SIMONSEN A H，MCGUIRE J，HANSSON O，et al. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to alzheimer dementia in patients with mild cognitive impairment[J]. Arch Neurol，2007，64（3）: 366-370. DOI：10.1001/archneur.64.3.366.
[32]	COMI C，CARECCHIO M，CHIOCCHETTI A，et al. Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline[J]. J Alzheimer's Dis，2010，19（4）：1143-1148. DOI：10.3233/jad-2010-1309.
[33]	DOWNEY C L，YOUNG A，BURTON E F，et al. Dementia and osteoporosis in a geriatric population：is there a common link?[J]. World J Orthop，2017，8（5）：412-423. DOI：10.5312/wjo.v8.i5.412
[34]	ZHAO L H .2020 Alzheimer's disease facts and figures[J]. Alzheimers Dement，2020，16（3）：391-460. DOI：10.1002/alz.12068
[35]	SOHRABI H R，BATES K A，WEINBORN M，et al. Bone mineral density，adiposity，and cognitive functions[J]. Front Aging Neurosci，2015，7：16. DOI：10.3389/fnagi.2015.00016.
[36]	ZHOU R，ZHOU H D，RUI L，et al. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer's disease[J]. Curr Alzheimer Res，2014，11（7）：706-713. DOI：10.2174/1567205011666140812115818.
[37]	TARRANT S M，BALOGH Z J. The global burden of surgical management of osteoporotic fractures[J]. World J Surg，2020，44（4）：1009-1019. DOI：10.1007/s00268-019-05237-y.
[38]	CAULEY J A，CAWTHON P M，PETERS K E，et al. Risk factors for hip fracture in older men：the osteoporotic fractures in men study （MrOS）[J]. J Bone Miner Res，2016，31（10）：1810-1819. DOI：10.1002/jbmr.2836.
[39]	KANG H G，PARK H Y，RYU H U，et al. Bone mineral loss and cognitive impairment[J]. Medicine，2018，97（41）: e12755. DOI：10.1097/md.0000000000012755.
[40]	CATALANO A，SARDELLA A，BELLONE F，et al. Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis[J]. Aging Clin Exp Res，2020，32（11）：2251-2257. DOI：10.1007/s40520-019-01426-w.
[41]	FOGG C，GRIFFITHS P，MEREDITH P，et al. Hospital outcomes of older people with cognitive impairment: an integrative review[J]. Int J Geriatr Psychiatry，2018，33（9）：1177-1197. DOI：10.1002/gps.4919.
[42]	HAO C T，CHUANG C S，Hung C H，et al. Fracture as an independent risk factor of dementia：a nationwide population-based cohort study[J]. Medicine （Baltimore），2014，93（26）：e188. DOI：10.1097/MD.0000000000000188.
[43]	LAVIKAINEN P，KOPONEN M，TAIPALE H，et al. Length of hospital stay for hip fracture and 30-day mortality in people with Alzheimer's disease: a cohort study in Finland[J]. Journals Gerontol: Ser A，2020，75（11）：2184-2192. DOI：10.1093/gerona/glaa199.
[44]	BERRY S D，ROTHBAUM R R，KIEL D P，et al. Association of clinical outcomes with surgical repair of hip fracture vs nonsurgical management in nursing home residents with advanced dementia[J]. JAMA Intern Med，2018，178（6）: 774-780. DOI：10.1001/jamainternmed.2018.0743.
[45]	BAE G，KIM E，KWON H Y，et al. Burden of osteoporotic fractures using disability-adjusted life years in South Korea[J]. Asia Pac J Public Heal，2020，32（2/3）：111-117. DOI：10.1177/1010539520916376.
[46]	CATALANO A，SARDELLA A，BELLONE F，et al. Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis[J]. Aging Clin Exp Res，2020，32（11）: 2251-2257. DOI：10.1007/s40520-019-01426-w.
[47]	MURTHY L，DREYER P，SURIYAARACHCHI P，et al. Association between high levels of parathyroid hormone and frailty：the Nepean Osteoporosis and Frailty （NOF） study[J]. J Frailty Aging，20187（4）:253-257. DOI：10.14283/jfa.2018.22.

Research Progress on the Relationship between Osteoporosis and Cognitive Impairment

骨质疏松与认知障碍关系的研究进展

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 47

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[2]	JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079.
[3]	XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840.
[4]	HE Li, ZHANG Yifan, SHEN Xuechun, SUN Yan, ZHAO Yang. Prevalence Trends of Multimorbidity among Residents in Mainland China: a Meta-analysis [J]. Chinese General Practice, 2023, 26(29): 3599-3607.
[5]	PAN Ye, LIU Zhihui, HU Qianqian, WANG Liuyi. Patterns of Coexistence of Multiple Chronic Conditions among Chinese Elderly [J]. Chinese General Practice, 2023, 26(29): 3608-3615.
[6]	ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621.
[7]	LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422.
[8]	TIAN Meng, SONG Yulei, ZHANG Xueqing, MA Yunyun, LIANG Xiao, SHI Jiarui, YIN Haiyan, LUO Dan, XU Guihua, BAI Yamei. Latent Profile Analysis of Sleep Subtypes in Older Adults with Subjective Cognitive Decline and Its Influencing Factors [J]. Chinese General Practice, 2023, 26(26): 3297-3302.
[9]	YIN Haiyan, SONG Yulei, XU Guihua, DU Shizheng, LUO Dan, ZHANG Xueqing, BAI Yamei. Effects of Intellectual Activities on Different Domains of Cognitive Function in Elderly People [J]. Chinese General Practice, 2023, 26(26): 3314-3319.
[10]	LIN Yang, WANG Fang, WANG Han, WU Rong, WANG Yao, XU Ziyao, WANG Xu, WANG Yanding. Prevalence of Frailty in Elderly Patients with Comorbidity: a Meta-analysis [J]. Chinese General Practice, 2023, 26(25): 3185-3193.
[11]	YANG Xuhong, WANG Minglei, LIU Wenxiao, MA Wanlong, ZHAO Jianguo, HUANG Xueying, WANG Minxing, DING Xiangchun, WANG Xiaodong. Evaluation of Cognitive Impairment in Patients with Minimal Hepatic Encephalopathy Based on Degree Centrality of Resting-state Blood Oxygenation Level-dependent Functional Magnetic Resonance Imaging [J]. Chinese General Practice, 2023, 26(24): 3033-3041.
[12]	ZENG Lingfeng, YANG Weiyi, LIANG Guihong, XIAO Xiao, LUO Minghui, PAN Jianke, HAN Yanhong, HUANG Hetao, ZHAO Jinlong, XU Nanjun, ZHOU Guanghui, ZHANG Xianquan, LIANG Weixiong, OU Aihua, LIU Jun, Bone and Joint Professional Committee of Degeneration and Injury of Guangdong Provincial Association of Chinese Medicine. Expert Questionnaire Survey and Result Analysis of TCM Symptom Assessment in High Risk Population of Osteoporosis in Ling-nan Region [J]. Chinese General Practice, 2023, 26(24): 2986-2991.
[13]	MENG Fan, DONG Minjie, GUO Jin, XU Songtao, YAN Wei, GU Jun, CHEN Yirong, YANG Cheng, WANG Jun, XIA Lifang, CHEN Jun, FU Lingjie. Osteoporosis in Community-dwelling Elderly People: Prevalence and Associated Prevention and Control Strategies in General Practice [J]. Chinese General Practice, 2023, 26(22): 2778-2784.
[14]	YU Yanxue, BAI Ruyu, YU Wenlong, GUO Xia, WU Li'e. Occurrence Status and Influencing Factors of Cognitive Dysfunction in Population Aged 60 and Above [J]. Chinese General Practice, 2023, 26(21): 2581-2588.
[15]	XU Haina, AN Miaomiao, ZHU Yan, WU Chunyan, RAN Limei. Associations of Muscle and Adipose Tissue with Bone Mineral Density in Premenopausal and Postmenopausal Women Undergoing Physical Examination [J]. Chinese General Practice, 2023, 26(21): 2626-2631.